Literature DB >> 6344651

Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.

E Ferrannini, J Wahren, O K Faber, P Felig, C Binder, R A DeFronzo.   

Abstract

Kinetic analyses of insulin metabolism were performed in 32 healthy subjects with hepatic-venous or renal-venous catheters, in whom steady-state conditions of hyperinsulinemia or hyperglycemia were achieved with the use of the glucose-insulin clamp technique. In the basal state, the splanchnic bed removed 42 +/- 2% of the insulin influx. After graded insulin infusions with maintenance of euglycemia, stable arterial insulin levels of 35-1,430 microU/ml were attained. Splanchnic insulin extraction was constant (approximately 60%) at physiological insulin levels but fell (to 29 +/- 1%, P less than 0.02) at supraphysiological (greater than 500 microU/ml) concentrations. The metabolic clearance rate of infused insulin was essentially constant within the physiological concentration range. Hyperglycemia (+125 mg/100 ml) did not alter splanchnic insulin extraction. Basally, the kidneys extracted 0.04 +/- 0.01 mU X min-1 X kg-1 or 25 +/- 5% of arterial insulin. Renal insulin clearance (3.9 +/- 0.4 ml X min-1 X kg-1) represented over 80% of the extrasplanchnic insulin clearance. Hyperglycemia (+125 mg/100 ml) had no effect on renal insulin extraction. In conclusion, a) both splanchnic and renal insulin removal are independent of glycemia and increase in proportion to plasma insulin concentration within the physiological range; b) splanchnic uptake is the dominant mechanism of removal of insulin from the circulation whether the route of delivery is portal or peripheral; and c) the kidneys account for the greater part of extrasplanchnic insulin metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344651     DOI: 10.1152/ajpendo.1983.244.6.E517

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  63 in total

1.  Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

Authors:  Felix Kulozik; Christoph Hasslacher
Journal:  Ther Adv Endocrinol Metab       Date:  2013-08       Impact factor: 3.565

2.  Acute blockade by endothelin-1 of haemodynamic insulin action in rats.

Authors:  R M Ross; C M Kolka; S Rattigan; M G Clark
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

Review 3.  Can technological solutions for diabetes replace islet cell function?

Authors:  Justin M Gregory; Daniel J Moore
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

4.  Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.

Authors:  Domenico Tricò; Andrea Natali; Silva Arslanian; Andrea Mari; Ele Ferrannini
Journal:  JCI Insight       Date:  2018-12-20

5.  A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.

Authors:  N Barzilai; P H Groop; L Groop; R A DeFronzo
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

6.  Intrahepatic fat, irrespective of ethnicity, is associated with reduced endogenous insulin clearance and hepatic insulin resistance in obese youths: A cross-sectional and longitudinal study from the Yale Pediatric NAFLD cohort.

Authors:  Domenico Tricò; Alfonso Galderisi; Andrea Mari; David Polidori; Brittany Galuppo; Bridget Pierpont; Stephanie Samuels; Nicola Santoro; Sonia Caprio
Journal:  Diabetes Obes Metab       Date:  2020-05-31       Impact factor: 6.577

Review 7.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

8.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

9.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

Authors:  A N Peiris; R A Mueller; G A Smith; M F Struve; A H Kissebah
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

10.  Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.

Authors:  Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.